Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Satellos Bioscience Inc Com V.ICO


Primary Symbol: ICOTF

iCo Therapeutics Inc is a Canada based biotechnology company. It is involved in the Research and development of ophthalmic indications. The company identifies, develops, and commercialize drug candidates with clinical history, and re-doses, reformulates and develops these drug candidates to treat sight and life-threatening diseases. Its in-licensed assets are iCo-008 and the Oral AmpB Delivery System. iCo-008 is a human monoclonal antibody targeting eotaxin-1 that acts as a messenger between...


GREY:ICOTF - Post by User

Comment by Alba1314on Jul 20, 2018 10:34am
82 Views
Post# 28344112

RE:Patience

RE:Patience
inthestockgame wrote: Remember we were supposed to get 2 news releases in July...The BIG news that we thought was coming on Monday was not it.  There are lots of good things coming with this company....Patience is all we need to have.  This will spike again soon!!


From NR on June 20th:
 
"We currently expect results from the Phase 1 study in early July 2018."
 
https://web.tmxmoney.com/article.php?newsid=7084357932820863&qm_symbol=ICO
 
Ok, so we got the reults on June 27th. From that NR:
 
""iCo Management waits with anticipation important and material pharmacokinetic data in the coming weeks."
 
ok, so we got that data on July 16:
 
https://web.tmxmoney.com/article.php?newsid=5798260894104632&qm_symbol=ICO
 
Where, in any of that, are you getting a "promise of TWO reports in July"? There's nothing left to report. The trial results are in, and the pharma data has been released. Time to move on. This story is going to take a few years to be told and for now this Phase I chapter is closed.
 
<< Previous
Bullboard Posts
Next >>